文献速递慢性肾脏病

糖尿病进展至ESKD的新型循环miRNA与轴突导向通路蛋白的系统搜索

Comprehensive Search for Novel Circulating miRNAs and Axon Guidance Pathway Proteins Associated with Risk of ESKD in Diabetes.
PubMed 文献 · J Am Soc Nephrol · 2021-06-17

本研究对375例晚期糖尿病肾病患者的血浆进行全局miRNA分析,并对746例早晚期患者的血浆进行靶向蛋白质组学分析。在晚期队列中鉴定出17种循环miRNA(以miR-1287-5p、miR-197-5p、miR-339-5p、miR-328-3p为代表)与10年ESKD风险强相关;这些miRNA靶向轴突导向通路蛋白,其中6种蛋白(尤以EFNA4和EPHA2为著)在所有队列中均与10年ESKD风险强相关,且与肾活检结构病变严重程度相关。体外实验显示特定miRNA模拟物或抑制剂可上调EPHA2浓度。

要点

  • 循环miR-1287-5p等4种miRNA与糖尿病10年ESKD风险强相关。
  • 轴突导向通路蛋白EFNA4和EPHA2与10年ESKD风险及肾活检病变严重程度相关。
  • 循环miRNA和轴突导向通路蛋白可能是防治糖尿病肾病的潜在靶点。

核心结论

  • 本研究揭示糖尿病进展至ESKD的新机制,提示全身性因素在糖尿病肾病发展中的重要性。
  • 部分循环miRNA和轴突导向通路蛋白可能成为预防和治疗糖尿病肾病的新靶点。

研究设计与样本

  • 对两个队列共375例1型和2型糖尿病晚期糖尿病肾病患者血浆进行全局miRNA分析。
  • 对四个队列共746例晚期和早期糖尿病肾病患者血浆进行靶向蛋白质组学分析。
  • 对105例早期糖尿病肾病患者肾活检标本进行结构病变检查。
  • 使用人脐静脉内皮细胞评估miRNA模拟物或抑制剂对候选蛋白的调控作用。

主要发现

  • 在晚期糖尿病肾病队列中鉴定出17种循环miRNA,以miR-1287-5p、miR-197-5p、miR-339-5p和miR-328-3p为代表,与10年ESKD风险强相关。
  • 这些miRNA靶向轴突导向通路蛋白,其中6种蛋白(尤以EFNA4和EPHA2为著)在所有队列中与10年ESKD风险强相关。
  • 这些蛋白的循环水平与肾活检标本结构病变严重程度相关,而编码这些蛋白的基因表达水平对病变无明显影响。
  • 体外实验中,miR-1287-5p和miR-197-5p的模拟物以及miR-339-5p和miR-328-3p的抑制剂可上调细胞裂解液、上清液或两者中EPHA2浓度。

临床怎么用

  • 循环miRNA和轴突导向通路蛋白(如EFNA4、EPHA2)可作为糖尿病肾病进展至ESKD的风险评估生物标志物。
  • 这些分子可能成为预防和治疗糖尿病肾病进展的新干预靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Mechanisms underlying the pro gression of diabetic kidney disease to ESKD are not fully understood. METHODS: We performed global microRNA (miRNA) analysis on plasma from two cohorts consisting of 375 individuals with type 1 and type 2 diabetes with late diabetic kidney disease, and targeted proteomics analysis on plasma from four cohorts consisting of 746 individuals with late and early diabetic kidney disease. We examined structural lesions in kidney biopsy specimens from the 105 individuals with early diabetic kidney disease. Human umbilical vein endothelial cells were used to assess the effects of miRNA mimics or inhibitors on regulation of candidate proteins. RESULTS: In the late diabetic kidney disease cohorts, we identified 17 circulating miRNAs, represented by four exemplars (miR-1287-5p, miR-197-5p, miR-339-5p, and miR-328-3p), that were strongly associated with 10-year risk of ESKD. These miRNAs targeted proteins in the axon guidance pathway. Circulating levels of six of these proteins-most notably, EFNA4 and EPHA2-were strongly associated with 10-year risk of ESKD in all cohorts. Furthermore, circulating levels of these proteins correlated with severity of structural lesions in kidney biopsy specimens. In contrast, expression levels of genes encoding these proteins had no apparent effects on the lesions. In in vitro experiments, mimics of miR-1287-5p and miR-197-5p and inhibitors of miR-339-5p and miR-328-3p upregulated concentrations of EPHA2 in either cell lysate, supernatant, or both. CONCLUSIONS: This study reveals novel mechanisms involved in progression to ESKD and points to the importance of systemic factors in the development of diabetic kidney disease. Some circulating miRNAs and axon guidance pathway proteins represent potential targets for new therapies to prevent and treat this condition.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Satake E, Saulnier PJ, Kobayashi H, et al. Comprehensive Search for Novel Circulating miRNAs and Axon Guidance Pathway Proteins Associated with Risk of ESKD in Diabetes. J Am Soc Nephrol. 2021. PMID: 34140396. doi:10.1681/ASN.2021010105

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。